NORTH CHICAGO, Ill. and BREDA, The Netherlands and GHENT, Belgium , April 21, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and argenx (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic

NORTH CHICAGO, Ill. , April 20, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 41 st Annual Health Care Conference on Wednesday, May 4, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at

NORTH CHICAGO, Ill. and INGELHEIM, Germany , March 7, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Boehringer Ingelheim today announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase 3 development for psoriasis.

NORTH CHICAGO, Ill. , April 7, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its first-quarter 2016 financial results on Thursday, April 28, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , March 8, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Barclays Global Healthcare Conference on Thursday, March 17, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 8 a.m.

NORTH CHICAGO, Ill. , Feb. 29, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Cowen and Company 36 th Annual Health Care Conference on Wednesday, March 9, 2016 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 8:20

NORTH CHICAGO, Ill. , Feb. 18, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable May 16, 2016 to stockholders of record at the close of business on April 15, 2016 .

- Reports Full-Year Adjusted EPS of $4.29, Up 29.2 Percent; GAAP EPS of $3.13 - Delivers Full-Year Adjusted Net Revenues of $22.819 Billion, Up 22.1 Percent on an Operational Basis; GAAP Net Revenues of $22.859 Billion, Up 14.5 Percent - Expanded Adjusted Operating Margin to 42.3 Percent in 2015,

NORTH CHICAGO, Ill. , Jan. 7, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2015 financial results on Friday, Jan. 29, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , Dec. 16, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 34 th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2016 . Richard A. Gonzalez , chairman and chief executive officer, will make a formal presentation on the company at 10:30 a.m.